The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000818:Animals; D002087:Butyrates; D002474:Cell-Free System; D000242:Cyclic AMP / Q000494:pharmacology; D003864:Depression, Chemical; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005934:Glucagon / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007657:Ketone Bodies / Q000096:biosynthesis; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009829:Oleic Acids / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism; D014508:Urea / Q000378:metabolism
D000227:Adenine Nucleotides; D002087:Butyrates; D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D008074:Lipoproteins; D009829:Oleic Acids; D014280:Triglycerides; D014508:Urea; D005934:Glucagon; D000242:Cyclic AMP; D005947:Glucose